APO Research
Talk to an analyst

APO RESEARCH · REPORT

Thrombin (Human)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Thrombin (Human) Market Analysis and Forecast 2026-2032

26 December 2025197 pages

Choose your research edition.

Industry ResearchThrombin (Human) Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Thrombin (Human) Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Thrombin (Human) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Thrombin (Human) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Thrombin (Human) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Thrombin (Human) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Thrombin (Human) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Thrombin (Human) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Thrombin (Human) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Thrombin (Human) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Thrombin (Human) include Shanghai RAAS, Hualan Biological, Bayer, Baxter, Vitrolife AB, Sigma-Aldrich Corporation, PromoCell GmbH, Octapharma and Life Technologies Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Thrombin (Human), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Thrombin (Human), also provides the sales of main regions and countries. Of the upcoming market potential for Thrombin (Human), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Thrombin (Human) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Thrombin (Human) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Thrombin (Human) sales, projected growth trends, production technology, application and end-user industry.

Thrombin (Human) Segment by Company

Shanghai RAAS

Hualan Biological

Bayer

Baxter

Vitrolife AB

Sigma-Aldrich Corporation

PromoCell GmbH

Octapharma

Life Technologies Corporation

Kedrion

Grifols

CSL

BD Biosciences

AMRESCO Inc

Thrombin (Human) Segment by Type

500IU/Vial

1000IU/Vial

2500IU/Vial

Thrombin (Human) Segment by Application

Biotechnology

Microbiology

Medicine

Others

Thrombin (Human) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Thrombin (Human) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Thrombin (Human) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Thrombin (Human).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Thrombin (Human) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Thrombin (Human) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Thrombin (Human) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Thrombin (Human) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 500IU/Vial Major Manufacturers Table 3. 1000IU/Vial Major Manufacturers Table 4. 2500IU/Vial Major Manufacturers Table 5. Global Thrombin (Human) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Biotechnology Major Manufacturers Table 7. Microbiology Major Manufacturers Table 8. Medicine Major Manufacturers Table 9. Others Major Manufacturers Table 10. Thrombin (Human) Industry Trends Table 11. Thrombin (Human) Industry Drivers Table 12. Thrombin (Human) Industry Opportunities and Challenges Table 13. Thrombin (Human) Industry Restraints Table 14. Global Thrombin (Human) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Thrombin (Human) Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Thrombin (Human) Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Thrombin (Human) Revenue Market Share by Region (2021-2026) Table 18. Global Thrombin (Human) Revenue Market Share by Region (2027-2032) Table 19. Global Thrombin (Human) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Thrombin (Human) Sales by Region (2021-2026) & (K Units) Table 21. Global Thrombin (Human) Sales by Region (2027-2032) & (K Units) Table 22. Global Thrombin (Human) Sales Market Share by Region (2021-2026) Table 23. Global Thrombin (Human) Sales Market Share by Region (2027-2032) Table 24. Global Thrombin (Human) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Thrombin (Human) Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Thrombin (Human) Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Thrombin (Human) Sales Market Share by Manufacturers (2021-2026) Table 28. Global Thrombin (Human) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Thrombin (Human) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Thrombin (Human) Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Thrombin (Human) Manufacturers, Product Type & Application Table 32. Global Thrombin (Human) Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Thrombin (Human) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Thrombin (Human) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Thrombin (Human) Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Thrombin (Human) Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Thrombin (Human) Revenue Market Share by Type (2021-2026) Table 39. Global Thrombin (Human) Revenue Market Share by Type (2027-2032) Table 40. Global Thrombin (Human) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Thrombin (Human) Sales by Type (2021-2026) & (K Units) Table 42. Global Thrombin (Human) Sales by Type (2027-2032) & (K Units) Table 43. Global Thrombin (Human) Sales Market Share by Type (2021-2026) Table 44. Global Thrombin (Human) Sales Market Share by Type (2027-2032) Table 45. Global Thrombin (Human) Price by Type (2021-2026) & (US$/Unit) Table 46. Global Thrombin (Human) Price by Type (2027-2032) & (US$/Unit) Table 47. Global Thrombin (Human) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Thrombin (Human) Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Thrombin (Human) Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Thrombin (Human) Revenue Market Share by Application (2021-2026) Table 51. Global Thrombin (Human) Revenue Market Share by Application (2027-2032) Table 52. Global Thrombin (Human) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Thrombin (Human) Sales by Application (2021-2026) & (K Units) Table 54. Global Thrombin (Human) Sales by Application (2027-2032) & (K Units) Table 55. Global Thrombin (Human) Sales Market Share by Application (2021-2026) Table 56. Global Thrombin (Human) Sales Market Share by Application (2027-2032) Table 57. Global Thrombin (Human) Price by Application (2021-2026) & (US$/Unit) Table 58. Global Thrombin (Human) Price by Application (2027-2032) & (US$/Unit) Table 59. Shanghai RAAS Company Information Table 60. Shanghai RAAS Business Overview Table 61. Shanghai RAAS Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Shanghai RAAS Thrombin (Human) Product Portfolio Table 63. Shanghai RAAS Recent Development Table 64. Hualan Biological Company Information Table 65. Hualan Biological Business Overview Table 66. Hualan Biological Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Hualan Biological Thrombin (Human) Product Portfolio Table 68. Hualan Biological Recent Development Table 69. Bayer Company Information Table 70. Bayer Business Overview Table 71. Bayer Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Bayer Thrombin (Human) Product Portfolio Table 73. Bayer Recent Development Table 74. Baxter Company Information Table 75. Baxter Business Overview Table 76. Baxter Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Baxter Thrombin (Human) Product Portfolio Table 78. Baxter Recent Development Table 79. Vitrolife AB Company Information Table 80. Vitrolife AB Business Overview Table 81. Vitrolife AB Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Vitrolife AB Thrombin (Human) Product Portfolio Table 83. Vitrolife AB Recent Development Table 84. Sigma-Aldrich Corporation Company Information Table 85. Sigma-Aldrich Corporation Business Overview Table 86. Sigma-Aldrich Corporation Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sigma-Aldrich Corporation Thrombin (Human) Product Portfolio Table 88. Sigma-Aldrich Corporation Recent Development Table 89. PromoCell GmbH Company Information Table 90. PromoCell GmbH Business Overview Table 91. PromoCell GmbH Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. PromoCell GmbH Thrombin (Human) Product Portfolio Table 93. PromoCell GmbH Recent Development Table 94. Octapharma Company Information Table 95. Octapharma Business Overview Table 96. Octapharma Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Octapharma Thrombin (Human) Product Portfolio Table 98. Octapharma Recent Development Table 99. Life Technologies Corporation Company Information Table 100. Life Technologies Corporation Business Overview Table 101. Life Technologies Corporation Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Life Technologies Corporation Thrombin (Human) Product Portfolio Table 103. Life Technologies Corporation Recent Development Table 104. Kedrion Company Information Table 105. Kedrion Business Overview Table 106. Kedrion Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Kedrion Thrombin (Human) Product Portfolio Table 108. Kedrion Recent Development Table 109. Grifols Company Information Table 110. Grifols Business Overview Table 111. Grifols Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Grifols Thrombin (Human) Product Portfolio Table 113. Grifols Recent Development Table 114. CSL Company Information Table 115. CSL Business Overview Table 116. CSL Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. CSL Thrombin (Human) Product Portfolio Table 118. CSL Recent Development Table 119. BD Biosciences Company Information Table 120. BD Biosciences Business Overview Table 121. BD Biosciences Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. BD Biosciences Thrombin (Human) Product Portfolio Table 123. BD Biosciences Recent Development Table 124. AMRESCO Inc Company Information Table 125. AMRESCO Inc Business Overview Table 126. AMRESCO Inc Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. AMRESCO Inc Thrombin (Human) Product Portfolio Table 128. AMRESCO Inc Recent Development Table 129. North America Thrombin (Human) Revenue by Type (2021-2026) & (US$ Million) Table 130. North America Thrombin (Human) Revenue by Type (2027-2032) & (US$ Million) Table 131. North America Thrombin (Human) Sales by Type (2021-2026) & (K Units) Table 132. North America Thrombin (Human) Sales by Type (2027-2032) & (K Units) Table 133. North America Thrombin (Human) Sales Price by Type (2021-2026) & (US$/Unit) Table 134. North America Thrombin (Human) Sales Price by Type (2027-2032) & (US$/Unit) Table 135. North America Thrombin (Human) Revenue by Application (2021-2026) & (US$ Million) Table 136. North America Thrombin (Human) Revenue by Application (2027-2032) & (US$ Million) Table 137. North America Thrombin (Human) Sales by Application (2021-2026) & (K Units) Table 138. North America Thrombin (Human) Sales by Application (2027-2032) & (K Units) Table 139. North America Thrombin (Human) Sales Price by Application (2021-2026) & (US$/Unit) Table 140. North America Thrombin (Human) Sales Price by Application (2027-2032) & (US$/Unit) Table 141. North America Thrombin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. North America Thrombin (Human) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. North America Thrombin (Human) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. North America Thrombin (Human) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 145. North America Thrombin (Human) Sales by Country (2021-2026) & (K Units) Table 146. North America Thrombin (Human) Sales by Country (2027-2032) & (K Units) Table 147. North America Thrombin (Human) Sales Price by Country (2021-2026) & (US$/Unit) Table 148. North America Thrombin (Human) Sales Price by Country (2027-2032) & (US$/Unit) Table 149. United States Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 150. Canada Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 151. Mexico Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 152. Europe Thrombin (Human) Revenue by Type (2021-2026) & (US$ Million) Table 153. Europe Thrombin (Human) Revenue by Type (2027-2032) & (US$ Million) Table 154. Europe Thrombin (Human) Sales by Type (2021-2026) & (K Units) Table 155. Europe Thrombin (Human) Sales by Type (2027-2032) & (K Units) Table 156. Europe Thrombin (Human) Sales Price by Type (2021-2026) & (US$/Unit) Table 157. Europe Thrombin (Human) Sales Price by Type (2027-2032) & (US$/Unit) Table 158. Europe Thrombin (Human) Revenue by Application (2021-2026) & (US$ Million) Table 159. Europe Thrombin (Human) Revenue by Application (2027-2032) & (US$ Million) Table 160. Europe Thrombin (Human) Sales by Application (2021-2026) & (K Units) Table 161. Europe Thrombin (Human) Sales by Application (2027-2032) & (K Units) Table 162. Europe Thrombin (Human) Sales Price by Application (2021-2026) & (US$/Unit) Table 163. Europe Thrombin (Human) Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Europe Thrombin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Europe Thrombin (Human) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Europe Thrombin (Human) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Europe Thrombin (Human) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 168. Europe Thrombin (Human) Sales by Country (2021-2026) & (K Units) Table 169. Europe Thrombin (Human) Sales by Country (2027-2032) & (K Units) Table 170. Europe Thrombin (Human) Sales Price by Country (2021-2026) & (US$/Unit) Table 171. Europe Thrombin (Human) Sales Price by Country (2027-2032) & (US$/Unit) Table 172. Germany Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 173. France Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 174. U.K. Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 175. Italy Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 176. Russia Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 177. Spain Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 178. Netherlands Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 179. Switzerland Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 180. Sweden Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 181. Poland Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 182. China Thrombin (Human) Revenue by Type (2021-2026) & (US$ Million) Table 183. China Thrombin (Human) Revenue by Type (2027-2032) & (US$ Million) Table 184. China Thrombin (Human) Sales by Type (2021-2026) & (K Units) Table 185. China Thrombin (Human) Sales by Type (2027-2032) & (K Units) Table 186. China Thrombin (Human) Sales Price by Type (2021-2026) & (US$/Unit) Table 187. China Thrombin (Human) Sales Price by Type (2027-2032) & (US$/Unit) Table 188. China Thrombin (Human) Revenue by Application (2021-2026) & (US$ Million) Table 189. China Thrombin (Human) Revenue by Application (2027-2032) & (US$ Million) Table 190. China Thrombin (Human) Sales by Application (2021-2026) & (K Units) Table 191. China Thrombin (Human) Sales by Application (2027-2032) & (K Units) Table 192. China Thrombin (Human) Sales Price by Application (2021-2026) & (US$/Unit) Table 193. China Thrombin (Human) Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Thrombin (Human) Revenue by Type (2021-2026) & (US$ Million) Table 195. Asia Thrombin (Human) Revenue by Type (2027-2032) & (US$ Million) Table 196. Asia Thrombin (Human) Sales by Type (2021-2026) & (K Units) Table 197. Asia Thrombin (Human) Sales by Type (2027-2032) & (K Units) Table 198. Asia Thrombin (Human) Sales Price by Type (2021-2026) & (US$/Unit) Table 199. Asia Thrombin (Human) Sales Price by Type (2027-2032) & (US$/Unit) Table 200. Asia Thrombin (Human) Revenue by Application (2021-2026) & (US$ Million) Table 201. Asia Thrombin (Human) Revenue by Application (2027-2032) & (US$ Million) Table 202. Asia Thrombin (Human) Sales by Application (2021-2026) & (K Units) Table 203. Asia Thrombin (Human) Sales by Application (2027-2032) & (K Units) Table 204. Asia Thrombin (Human) Sales Price by Application (2021-2026) & (US$/Unit) Table 205. Asia Thrombin (Human) Sales Price by Application (2027-2032) & (US$/Unit) Table 206. Asia Thrombin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. Asia Thrombin (Human) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. Asia Thrombin (Human) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. Asia Thrombin (Human) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 210. Asia Thrombin (Human) Sales by Country (2021-2026) & (K Units) Table 211. Asia Thrombin (Human) Sales by Country (2027-2032) & (K Units) Table 212. Asia Thrombin (Human) Sales Price by Country (2021-2026) & (US$/Unit) Table 213. Asia Thrombin (Human) Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Japan Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 215. South Korea Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 216. India Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 217. Australia Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 218. Taiwan Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 219. Southeast Asia Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 220. SAMEA Thrombin (Human) Revenue by Type (2021-2026) & (US$ Million) Table 221. SAMEA Thrombin (Human) Revenue by Type (2027-2032) & (US$ Million) Table 222. SAMEA Thrombin (Human) Sales by Type (2021-2026) & (K Units) Table 223. SAMEA Thrombin (Human) Sales by Type (2027-2032) & (K Units) Table 224. SAMEA Thrombin (Human) Sales Price by Type (2021-2026) & (US$/Unit) Table 225. SAMEA Thrombin (Human) Sales Price by Type (2027-2032) & (US$/Unit) Table 226. SAMEA Thrombin (Human) Revenue by Application (2021-2026) & (US$ Million) Table 227. SAMEA Thrombin (Human) Revenue by Application (2027-2032) & (US$ Million) Table 228. SAMEA Thrombin (Human) Sales by Application (2021-2026) & (K Units) Table 229. SAMEA Thrombin (Human) Sales by Application (2027-2032) & (K Units) Table 230. SAMEA Thrombin (Human) Sales Price by Application (2021-2026) & (US$/Unit) Table 231. SAMEA Thrombin (Human) Sales Price by Application (2027-2032) & (US$/Unit) Table 232. SAMEA Thrombin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 233. SAMEA Thrombin (Human) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 234. SAMEA Thrombin (Human) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 235. SAMEA Thrombin (Human) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 236. SAMEA Thrombin (Human) Sales by Country (2021-2026) & (K Units) Table 237. SAMEA Thrombin (Human) Sales by Country (2027-2032) & (K Units) Table 238. SAMEA Thrombin (Human) Sales Price by Country (2021-2026) & (US$/Unit) Table 239. SAMEA Thrombin (Human) Sales Price by Country (2027-2032) & (US$/Unit) Table 240. Brazil Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 241. Argentina Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 242. Chile Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 243. Colombia Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 244. Peru Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 245. Saudi Arabia Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 246. Israel Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 247. UAE Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 248. Turkey Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 249. Iran Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 250. Egypt Thrombin (Human) Revenue (2021-2032) & (US$ Million) Table 251. Key Raw Materials Table 252. Raw Materials Key Suppliers Table 253. Thrombin (Human) Distributors List Table 254. Thrombin (Human) Customers List Table 255. Research Programs/Design for This Report Table 256. Authors List of This Report Table 257. Secondary Sources Table 258. Primary Sources List of Figures Figure 1. Thrombin (Human) Image Figure 2. Global Thrombin (Human) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Thrombin (Human) Market Size Share 2021 VS 2025 VS 2032 Figure 4. 500IU/Vial Image Figure 5. 1000IU/Vial Image Figure 6. 2500IU/Vial Image Figure 7. Global Thrombin (Human) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Thrombin (Human) Market Size Share 2021 VS 2025 VS 2032 Figure 9. Biotechnology Image Figure 10. Microbiology Image Figure 11. Medicine Image Figure 12. Others Image Figure 13. Global Thrombin (Human) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Thrombin (Human) Revenue (2021-2032) & (US$ Million) Figure 15. Global Thrombin (Human) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Thrombin (Human) Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Thrombin (Human) Revenue Market Share by Region (2021-2032) Figure 18. Global Thrombin (Human) Sales (2021-2032) & (K Units) Figure 19. Global Thrombin (Human) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Thrombin (Human) Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Thrombin (Human) Sales YoY (2021-2032) & (K Units) Figure 22. Europe Thrombin (Human) Sales YoY (2021-2032) & (K Units) Figure 23. China Thrombin (Human) Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Thrombin (Human) Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Thrombin (Human) Sales YoY (2021-2032) & (K Units) Figure 26. Global Thrombin (Human) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Thrombin (Human) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Thrombin (Human) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Thrombin (Human) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Thrombin (Human) Revenue Market Share by Type (2021-2032) Figure 32. Global Thrombin (Human) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Thrombin (Human) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Thrombin (Human) Sales Market Share by Type (2021-2032) Figure 35. Global Thrombin (Human) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Thrombin (Human) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Thrombin (Human) Revenue Market Share by Application (2021-2032) Figure 38. Global Thrombin (Human) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Thrombin (Human) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Thrombin (Human) Sales Market Share by Application (2021-2032) Figure 41. North America Thrombin (Human) Revenue Share by Type (2021-2032) Figure 42. North America Thrombin (Human) Sales Share by Type (2021-2032) Figure 43. North America Thrombin (Human) Revenue Share by Application (2021-2032) Figure 44. North America Thrombin (Human) Sales Share by Application (2021-2032) Figure 45. North America Thrombin (Human) Revenue Share by Country (2021-2032) Figure 46. North America Thrombin (Human) Sales Share by Country (2021-2032) Figure 47. Europe Thrombin (Human) Revenue Share by Type (2021-2032) Figure 48. Europe Thrombin (Human) Sales Share by Type (2021-2032) Figure 49. Europe Thrombin (Human) Revenue Share by Application (2021-2032) Figure 50. Europe Thrombin (Human) Sales Share by Application (2021-2032) Figure 51. Europe Thrombin (Human) Revenue Share by Country (2021-2032) Figure 52. Europe Thrombin (Human) Sales Share by Country (2021-2032) Figure 53. China Thrombin (Human) Revenue Share by Type (2021-2032) Figure 54. China Thrombin (Human) Sales Share by Type (2021-2032) Figure 55. China Thrombin (Human) Revenue Share by Application (2021-2032) Figure 56. China Thrombin (Human) Sales Share by Application (2021-2032) Figure 57. Asia Thrombin (Human) Revenue Share by Type (2021-2032) Figure 58. Asia Thrombin (Human) Sales Share by Type (2021-2032) Figure 59. Asia Thrombin (Human) Revenue Share by Application (2021-2032) Figure 60. Asia Thrombin (Human) Sales Share by Application (2021-2032) Figure 61. Asia Thrombin (Human) Revenue Share by Country (2021-2032) Figure 62. Asia Thrombin (Human) Sales Share by Country (2021-2032) Figure 63. SAMEA Thrombin (Human) Revenue Share by Type (2021-2032) Figure 64. SAMEA Thrombin (Human) Sales Share by Type (2021-2032) Figure 65. SAMEA Thrombin (Human) Revenue Share by Application (2021-2032) Figure 66. SAMEA Thrombin (Human) Sales Share by Application (2021-2032) Figure 67. SAMEA Thrombin (Human) Revenue Share by Country (2021-2032) Figure 68. SAMEA Thrombin (Human) Sales Share by Country (2021-2032) Figure 69. Thrombin (Human) Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Thrombin (Human) Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 500IU/Vial
  • 1000IU/Vial
  • 2500IU/Vial
Applications
  • Biotechnology
  • Microbiology
  • Medicine
  • Others
Companies covered
  • Shanghai RAAS
  • Hualan Biological
  • Bayer
  • Baxter
  • Vitrolife AB
  • Sigma-Aldrich Corporation
  • PromoCell GmbH
  • Octapharma
  • Life Technologies Corporation
  • Kedrion
  • Grifols
  • CSL
  • BD Biosciences
  • AMRESCO Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Thrombin (Human) Market by Type
  3. 1.2.1 Global Thrombin (Human) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 500IU/Vial
  5. 1.2.3 1000IU/Vial
  6. 1.2.4 2500IU/Vial
  7. 1.3 Thrombin (Human) Market by Application
  8. 1.3.1 Global Thrombin (Human) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Biotechnology
  10. 1.3.3 Microbiology
  11. 1.3.4 Medicine
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Thrombin (Human) Market Dynamics
  1. 2.1 Thrombin (Human) Industry Trends
  2. 2.2 Thrombin (Human) Industry Drivers
  3. 2.3 Thrombin (Human) Industry Opportunities and Challenges
  4. 2.4 Thrombin (Human) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Thrombin (Human) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Thrombin (Human) Revenue by Region
  3. 3.2.1 Global Thrombin (Human) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Thrombin (Human) Revenue by Region (2021-2026)
  5. 3.2.3 Global Thrombin (Human) Revenue by Region (2027-2032)
  6. 3.2.4 Global Thrombin (Human) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Thrombin (Human) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Thrombin (Human) Sales by Region
  9. 3.4.1 Global Thrombin (Human) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Thrombin (Human) Sales by Region (2021-2026)
  11. 3.4.3 Global Thrombin (Human) Sales by Region (2027-2032)
  12. 3.4.4 Global Thrombin (Human) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Thrombin (Human) Revenue by Manufacturers
  2. 4.1.1 Global Thrombin (Human) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Thrombin (Human) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Thrombin (Human) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Thrombin (Human) Sales by Manufacturers
  6. 4.2.1 Global Thrombin (Human) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Thrombin (Human) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Thrombin (Human) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Thrombin (Human) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Thrombin (Human) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Thrombin (Human) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Thrombin (Human) Manufacturers, Product Type & Application
  13. 4.7 Global Thrombin (Human) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Thrombin (Human) Market CR5 and HHI
  16. 4.8.2 2025 Thrombin (Human) Tier 1, Tier 2, and Tier 3
5 Thrombin (Human) Market by Type
  1. 5.1 Global Thrombin (Human) Revenue by Type
  2. 5.1.1 Global Thrombin (Human) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Thrombin (Human) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Thrombin (Human) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Thrombin (Human) Sales by Type
  6. 5.2.1 Global Thrombin (Human) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Thrombin (Human) Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Thrombin (Human) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Thrombin (Human) Price by Type
6 Thrombin (Human) Market by Application
  1. 6.1 Global Thrombin (Human) Revenue by Application
  2. 6.1.1 Global Thrombin (Human) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Thrombin (Human) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Thrombin (Human) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Thrombin (Human) Sales by Application
  6. 6.2.1 Global Thrombin (Human) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Thrombin (Human) Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Thrombin (Human) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Thrombin (Human) Price by Application
7 Company Profiles
  1. 7.1 Shanghai RAAS
  2. 7.1.1 Shanghai RAAS Company Information
  3. 7.1.2 Shanghai RAAS Business Overview
  4. 7.1.3 Shanghai RAAS Thrombin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Shanghai RAAS Thrombin (Human) Product Portfolio
  6. 7.1.5 Shanghai RAAS Recent Developments
  7. 7.2 Hualan Biological
  8. 7.2.1 Hualan Biological Company Information
  9. 7.2.2 Hualan Biological Business Overview
  10. 7.2.3 Hualan Biological Thrombin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Hualan Biological Thrombin (Human) Product Portfolio
  12. 7.2.5 Hualan Biological Recent Developments
  13. 7.3 Bayer
  14. 7.3.1 Bayer Company Information
  15. 7.3.2 Bayer Business Overview
  16. 7.3.3 Bayer Thrombin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bayer Thrombin (Human) Product Portfolio
  18. 7.3.5 Bayer Recent Developments
  19. 7.4 Baxter
  20. 7.4.1 Baxter Company Information
  21. 7.4.2 Baxter Business Overview
  22. 7.4.3 Baxter Thrombin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Baxter Thrombin (Human) Product Portfolio
  24. 7.4.5 Baxter Recent Developments
  25. 7.5 Vitrolife AB
  26. 7.5.1 Vitrolife AB Company Information
  27. 7.5.2 Vitrolife AB Business Overview
  28. 7.5.3 Vitrolife AB Thrombin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Vitrolife AB Thrombin (Human) Product Portfolio
  30. 7.5.5 Vitrolife AB Recent Developments
  31. 7.6 Sigma-Aldrich Corporation
  32. 7.6.1 Sigma-Aldrich Corporation Company Information
  33. 7.6.2 Sigma-Aldrich Corporation Business Overview
  34. 7.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sigma-Aldrich Corporation Thrombin (Human) Product Portfolio
  36. 7.6.5 Sigma-Aldrich Corporation Recent Developments
  37. 7.7 PromoCell GmbH
  38. 7.7.1 PromoCell GmbH Company Information
  39. 7.7.2 PromoCell GmbH Business Overview
  40. 7.7.3 PromoCell GmbH Thrombin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 PromoCell GmbH Thrombin (Human) Product Portfolio
  42. 7.7.5 PromoCell GmbH Recent Developments
  43. 7.8 Octapharma
  44. 7.8.1 Octapharma Company Information
  45. 7.8.2 Octapharma Business Overview
  46. 7.8.3 Octapharma Thrombin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Octapharma Thrombin (Human) Product Portfolio
  48. 7.8.5 Octapharma Recent Developments
  49. 7.9 Life Technologies Corporation
  50. 7.9.1 Life Technologies Corporation Company Information
  51. 7.9.2 Life Technologies Corporation Business Overview
  52. 7.9.3 Life Technologies Corporation Thrombin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Life Technologies Corporation Thrombin (Human) Product Portfolio
  54. 7.9.5 Life Technologies Corporation Recent Developments
  55. 7.10 Kedrion
  56. 7.10.1 Kedrion Company Information
  57. 7.10.2 Kedrion Business Overview
  58. 7.10.3 Kedrion Thrombin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Kedrion Thrombin (Human) Product Portfolio
  60. 7.10.5 Kedrion Recent Developments
  61. 7.11 Grifols
  62. 7.11.1 Grifols Company Information
  63. 7.11.2 Grifols Business Overview
  64. 7.11.3 Grifols Thrombin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Grifols Thrombin (Human) Product Portfolio
  66. 7.11.5 Grifols Recent Developments
  67. 7.12 CSL
  68. 7.12.1 CSL Company Information
  69. 7.12.2 CSL Business Overview
  70. 7.12.3 CSL Thrombin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 CSL Thrombin (Human) Product Portfolio
  72. 7.12.5 CSL Recent Developments
  73. 7.13 BD Biosciences
  74. 7.13.1 BD Biosciences Company Information
  75. 7.13.2 BD Biosciences Business Overview
  76. 7.13.3 BD Biosciences Thrombin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 BD Biosciences Thrombin (Human) Product Portfolio
  78. 7.13.5 BD Biosciences Recent Developments
  79. 7.14 AMRESCO Inc
  80. 7.14.1 AMRESCO Inc Company Information
  81. 7.14.2 AMRESCO Inc Business Overview
  82. 7.14.3 AMRESCO Inc Thrombin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 AMRESCO Inc Thrombin (Human) Product Portfolio
  84. 7.14.5 AMRESCO Inc Recent Developments
8 North America
  1. 8.1 North America Thrombin (Human) Market Size by Type
  2. 8.1.1 North America Thrombin (Human) Revenue by Type (2021-2032)
  3. 8.1.2 North America Thrombin (Human) Sales by Type (2021-2032)
  4. 8.1.3 North America Thrombin (Human) Price by Type (2021-2032)
  5. 8.2 North America Thrombin (Human) Market Size by Application
  6. 8.2.1 North America Thrombin (Human) Revenue by Application (2021-2032)
  7. 8.2.2 North America Thrombin (Human) Sales by Application (2021-2032)
  8. 8.2.3 North America Thrombin (Human) Price by Application (2021-2032)
  9. 8.3 North America Thrombin (Human) Market Size by Country
  10. 8.3.1 North America Thrombin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Thrombin (Human) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Thrombin (Human) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Thrombin (Human) Market Size by Type
  2. 9.1.1 Europe Thrombin (Human) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Thrombin (Human) Sales by Type (2021-2032)
  4. 9.1.3 Europe Thrombin (Human) Price by Type (2021-2032)
  5. 9.2 Europe Thrombin (Human) Market Size by Application
  6. 9.2.1 Europe Thrombin (Human) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Thrombin (Human) Sales by Application (2021-2032)
  8. 9.2.3 Europe Thrombin (Human) Price by Application (2021-2032)
  9. 9.3 Europe Thrombin (Human) Market Size by Country
  10. 9.3.1 Europe Thrombin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Thrombin (Human) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Thrombin (Human) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Thrombin (Human) Market Size by Type
  2. 10.1.1 China Thrombin (Human) Revenue by Type (2021-2032)
  3. 10.1.2 China Thrombin (Human) Sales by Type (2021-2032)
  4. 10.1.3 China Thrombin (Human) Price by Type (2021-2032)
  5. 10.2 China Thrombin (Human) Market Size by Application
  6. 10.2.1 China Thrombin (Human) Revenue by Application (2021-2032)
  7. 10.2.2 China Thrombin (Human) Sales by Application (2021-2032)
  8. 10.2.3 China Thrombin (Human) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Thrombin (Human) Market Size by Type
  2. 11.1.1 Asia Thrombin (Human) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Thrombin (Human) Sales by Type (2021-2032)
  4. 11.1.3 Asia Thrombin (Human) Price by Type (2021-2032)
  5. 11.2 Asia Thrombin (Human) Market Size by Application
  6. 11.2.1 Asia Thrombin (Human) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Thrombin (Human) Sales by Application (2021-2032)
  8. 11.2.3 Asia Thrombin (Human) Price by Application (2021-2032)
  9. 11.3 Asia Thrombin (Human) Market Size by Country
  10. 11.3.1 Asia Thrombin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Thrombin (Human) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Thrombin (Human) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Thrombin (Human) Market Size by Type
  2. 12.1.1 SAMEA Thrombin (Human) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Thrombin (Human) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Thrombin (Human) Price by Type (2021-2032)
  5. 12.2 SAMEA Thrombin (Human) Market Size by Application
  6. 12.2.1 SAMEA Thrombin (Human) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Thrombin (Human) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Thrombin (Human) Price by Application (2021-2032)
  9. 12.3 SAMEA Thrombin (Human) Market Size by Country
  10. 12.3.1 SAMEA Thrombin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Thrombin (Human) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Thrombin (Human) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Thrombin (Human) Value Chain Analysis
  2. 13.1.1 Thrombin (Human) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Thrombin (Human) Production Mode & Process
  6. 13.2 Thrombin (Human) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Thrombin (Human) Distributors
  9. 13.2.3 Thrombin (Human) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst